1. Dexmedetomidine protected COPD-induced lung injury by regulating miRNA-146a
- Author
-
D D Xing, N Li, J Liu, B S Ouyang, C S Lin, and L Liu
- Subjects
0301 basic medicine ,Economics and Econometrics ,Acute Lung Injury ,Interleukin-1beta ,Anti-Inflammatory Agents ,H&E stain ,Apoptosis ,Pharmacology ,Lung injury ,Rats, Sprague-Dawley ,Pulmonary Disease, Chronic Obstructive ,03 medical and health sciences ,FEV1/FVC ratio ,Gene expression ,Materials Chemistry ,Media Technology ,medicine ,Animals ,Dexmedetomidine ,EF50 ,Lung ,COPD ,Tumor Necrosis Factor-alpha ,business.industry ,Forestry ,medicine.disease ,Rats ,Respiratory Function Tests ,respiratory tract diseases ,Disease Models, Animal ,MicroRNAs ,030104 developmental biology ,Gene Expression Regulation ,Anesthesia ,business ,medicine.drug - Abstract
OBJECTIVE To study the mechanism of protection provided by dexmedetomidine against COPD-induced lung injury. METHODS COPD rat model was determined by measuring lung function, and comparing HE staining between two different groups. We got the lung tissue and cells from the control and COPD groups. The cells were divided into three groups: control group, and blank and drug groups that were from the COPD rats. Cell apoptosis, relative gene expression and TNF-α and IL-1β from nutrient solution were measured. RESULTS The TV, PEF, EF50, FEV0.3 and FEV0.3/FVC in COPD group were significantly lower than in control group (1.26±0.17 vs 2.65±0.21; 17.61±0.35 vs 38.55±0.24; 1.20±0.14 vs 1.81±0.06; 2.52±0.28 vs 4.44±0.26; 63.39±0.22 vs 88.45±0.34, p < 0.05, respectively). Cell apoptosis was significantly different in blank and drug groups (21.65±0.86 vs 10.74±0.15; p < 0.05, respectively). The gene expressions of miRNA-146a, p53 and Bcl-2 were significantly downregulated compared with blank group. CONCLUSION Dexmedetomidine protected COPD-induced lung injury by inhibiting miRNA-146a expression to reduce cell apoptosis (Tab. 1, Fig. 3, Ref. 25).
- Published
- 2016
- Full Text
- View/download PDF